上海招聘

公司目前拟招收由跨国制药公司资助的多名博士后研究人员，主要课题以基础科学研究为主，并以国际期刊发表论文为目标，每年提供至少一次参加国际学术会议的机会。在辉源公司，您将会接触到现代的药物开发技术，先进的科学仪器，动物设施，宽敞的实验室空间，多样化和跨学科的研究团队，及经验丰富的科研人员。博士后的研究将由在美国大制药公司工作的资深科学家指导，并有机会交流和访问美国公司。

研究方向：研究目标是鉴别并描述重要的肿瘤信号途径，阐明它们在肿瘤发生及肿瘤生长、转移的中的作用，首先为发表有影响力的文章，其次是为亚洲人群普遍发生的癌症治疗的药物开发中进行靶点和生物标志物的识别。

应征要求：具有肿瘤生物学，细胞生物学、分子生物学、生物化学或相关学科博士学位。接受过良好的肿瘤生物学、细胞生物学、生物化学和分子生物学训练，并在攻读博士学位期间在科学期刊上发表过学术论文。

申请程序：应聘者请将申请材料（申请表、简历、研究工作经历、发表论文情况及代表性论文PDF、两位推荐人的姓名及电话号码）上传或发送至指定邮箱。

We currently have openings for several Postdoctoral positions that will be funded by global pharmaceutical company. Research projects will focus on the basic research, with emphasis on publication in peer-reviewed journals. The funding provides opportunity to attend/present international conference at least once a year. At HDB, you will expose to modern drug R&D technologies, advanced scientific instrument, animal facilities, spacious laboratories, multi and interdisciplinary teams, very well seasoned and accomplished scientists. Your postdoctoral research will be supervised by senior scientists in the major US-based multinational pharmaceutical company and opportunities to interact with and visit the company.

Research direction：

The objectives of the research efforts are to identify and characterize key cancer signaling pathways and elucidate their roles in tumorigenesis and tumor growth/metastasis, firstly, for high impact publications and secondly, for the identification of targets and biomarkers in drug discovery for the treatment of Asian prevalent cancers.

Requirements:

Must have a PhD degree as well as good technical trainings in cancer biology, cell biology, molecular biology and biochemistry. Candidates should have publications from graduate studies;

How to apply:

Submit application materials (application form, a copy of curriculum vitae, a summary of research or working experience, a publication list and representative publication in PDF, the contact information of two references). Qualified applications will be considered immediately.

辉源生物科技（上海）有限公司是药明康德全资子公司，成立于2008年，2017年加入药明康德集团，公司总部位于上海，在美国加利福尼亚州设有分公司，是被行业认可的以高水平生物研发和生物技术为核心的临床前药物研发外包服务公司。我们的服务平台包括药物标靶发现验证，高通量药物筛选，基于微孔板的药理学检测，活性化合物识别，先导化合物开发，治疗性抗体研发，动物药效药理，药代动力学研究及其他生物研发服务。公司目前的研发服务涉及全球各大药企业，同时也为国内外众多中小型制药企业和生物公司提供全面完整的技术服务和专业指导。领先的专业技术和高质量的服务水平使辉源生物在临床前生物医药研发域享有盛誉。